SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001140361-21-020071
Filing Date
2021-06-07
Accepted
2021-06-07 16:21:11
Documents
5

Document Format Files

Seq Description Document Type Size
1 FORM 424B5 nt10025479x2_424b5.htm 424B5 869082
2 logo_ocuphire.jpg GRAPHIC 104265
3 logo_ocuphirex1.jpg GRAPHIC 90600
4 logo_ocuphirex3.jpg GRAPHIC 75522
5 nt10025479x2_chart1.jpg GRAPHIC 195245
  Complete submission text file 0001140361-21-020071.txt   1510902
Mailing Address 37000 GRAND RIVER AVE. SUITE 120 FARMINGTON HILLS MI 48335
Business Address 37000 GRAND RIVER AVE. SUITE 120 FARMINGTON HILLS MI 48335 248-681-9815
Ocuphire Pharma, Inc. (Filer) CIK: 0001228627 (see all company filings)

IRS No.: 113516358 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-252715 | Film No.: 21999767
SIC: 2834 Pharmaceutical Preparations